Ameriprise Financial Inc Repligen Corp Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Repligen Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 894,445 shares of RGEN stock, worth $133 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

894,445

Previous 984,788 9.17%

Holding current value

$133 Million

Previous $177 Million 7.09%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $15.4 Million - $18.8 Million	-90,343 Reduced 9.17%	894,445 $165 Million
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $19.2 Million - $31.2 Million	-168,417 Reduced 14.6%	984,788 $177 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $16.6 Million - $21.2 Million	-119,936 Reduced 9.42%	1,153,205 $183 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $28.8 Million - $37.5 Million	208,010 Added 19.53%	1,273,141 $180 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $2.98 Million - $3.83 Million	-19,337 Reduced 1.78%	1,065,131 $179 Million

Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $6.68 Million - $9.07 Million	-41,103 Reduced 3.65%	1,084,468 $184 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $29.3 Million - $46.7 Million	-182,463 Reduced 13.95%	1,125,571 $211 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $6.57 Million - $8.79 Million	-46,726 Reduced 3.45%	1,308,034 $212 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $25.2 Million - $40.3 Million	156,085 Added 13.02%	1,354,760 $255 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $119 Million - $146 Million	479,994 Added 66.79%	1,198,675 $317 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $1.13 Million - $1.89 Million	5,819 Added 0.82%	718,681 $208 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $58.8 Million - $78.3 Million	354,483 Added 98.91%	712,862 $142 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $46.4 Million - $58.3 Million	-257,490 Reduced 41.81%	358,379 $69.7 Million
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $4.82 Million - $6.72 Million	-32,544 Reduced 5.02%	615,869 $118 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $18 Million - $23.2 Million	146,604 Added 29.22%	648,413 $95.7 Million
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $14.4 Million - $21.4 Million	-152,594 Reduced 23.32%	501,809 $62 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $30.4 Million - $39.1 Million	358,369 Added 121.06%	654,403 $63.2 Million
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $546,342 - $688,698	-7,399 Reduced 2.44%	296,034 $27.4 Million
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $11.8 Million - $14.6 Million	-153,320 Reduced 33.57%	303,433 $23.3 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $542,433 - $860,187	-10,008 Reduced 2.14%	456,753 $39.3 Million
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $8.53 Million - $10.8 Million	-172,407 Reduced 26.97%	466,761 $27.6 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $12.4 Million - $17.6 Million	-256,084 Reduced 28.6%	639,168 $33.7 Million
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $100,105 - $126,136	-2,139 Reduced 0.24%	895,252 $49.6 Million
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $4.26 Million - $5.68 Million	120,824 Added 15.56%	897,391 $42.2 Million
Q1 2018 May 15, 2018	BUY	$30.92 - $37.27 $7.76 Million - $9.35 Million	250,845 Added 47.71%	776,567 $28.1 Million
Q4 2017 Feb 12, 2018	BUY	$32.53 - $38.92 $3.6 Million - $4.31 Million	110,761 Added 26.69%	525,722 $19.1 Million
Q3 2017 Nov 07, 2017	BUY	$36.98 - $46.06 $15.3 Million - $19.1 Million	414,961	414,961 $15.9 Million

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.27B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Repligen Corp Transaction History